+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Asia Pacific Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Product, and End User

  • PDF Icon

    Report

  • 73 Pages
  • September 2022
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5668330
UP TO OFF until Dec 31st 2024
The hemodialysis and peritoneal dialysis market in Asia Pacific is expected to grow from US$ 19,255.20 million in 2022 to US$ 29,972.11 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2022 to 2028.

The increasing preference for home care dialysis is the major factor driving the Asia Pacific hemodialysis and peritoneal dialysis market. Home hemodialysis (HHD) is a kidney replacement modality for patients with end-stage kidney disease (ESKD) that can be performed safely in the patient’s home environment. It requires the assistance of a trained caregiver or qualified hemodialysis nurse. The frequency of treatment for HHD can vary as per the patient. HHD can be performed as conventional HHD, with treatments 3 days a week for 3 to 4 hours or longer each time. It can also be performed as a short daily HHD, occurring 5 to 7 times a week for a shorter duration. Lastly, it can be performed overnight as nocturnal HHD, where treatments normally last 6 to 8 hours. New, easy-to-use machines are being developed for home hemodialysis. These are easier to set up, clean, and disinfect. Although the increasing reimbursement of home dialysis would seem to be an appropriate strategy to stimulate uptake of these modalities, evidence from regions that offer high reimbursement rates for peritoneal dialysis (PD) suggests that the success of this strategy is variable.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific hemodialysis and peritoneal dialysis market. The Asia Pacific hemodialysis and peritoneal dialysis market is expected to grow at a good CAGR during the forecast period.

Asia Pacific Hemodialysis and Peritoneal Dialysis Market Segmentation

The Asia Pacific hemodialysis and peritoneal dialysis market is segmented into type, product, end user, and country.
  • Based on type, the market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment is expected to hold a larger market share.
  • Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment is likely to hold the largest market share in 2022.
  • Based on end user, the market is segmented into hospital-based and home-based. The hospital-based segment is expected to account for a larger share in 2022.
  • Based on country, the Asia Pacific hemodialysis and peritoneal dialysis market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China is anticipated to hold the largest market share in 2022.
Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Dialife SA; Diaverum; Fresenius Medical Care AG & Co KGaA; Nipro Medical Corporation; and Rockwell Medical, Inc. are among the leading companies operating in the Asia Pacific hemodialysis and peritoneal dialysis market.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Hemodialysis and Peritoneal Dialysis Market - By Type
1.3.2 APAC Hemodialysis and Peritoneal Dialysis Market - By Product
1.3.3 APAC Hemodialysis and Peritoneal Dialysis Market - By End User
1.3.4 APAC Hemodialysis and Peritoneal Dialysis Market - By Country
2. APAC Hemodialysis and Peritoneal Dialysis Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Hemodialysis and Peritoneal Dialysis Market - Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Expert Opinion
5. APAC Hemodialysis and Peritoneal Dialysis Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Kidney Diseases Becoming More Common
5.1.2 Increasing Prevalence of Diabetes
5.2 Market Restraints
5.2.1 Risks and Complications with Dialysis
5.3 Market Opportunities
5.3.1 Home Care Dialysis Given Preference
5.4 Future Trends
5.4.1 Major Players Adopting New Market Strategies
5.5 Impact Analysis
6. Haemodialysis and Peritoneal Dialysis Market- APAC Analysis
6.1 APAC Haemodialysis and Peritoneal Dialysis Market Revenue Forecast and Analysis
6.2 APAC Haemodialysis and Peritoneal Dialysis Market, By Country - Forecast and Analysis
7. APAC Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028- by Type
7.1 Overview
7.2 APAC Haemodialysis and Peritoneal Dialysis Market, By Type, 2022 & 2028 (%)
7.3 Haemodialysis
7.3.1 Overview
7.3.2 Haemodialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Peritoneal Dialysis
7.4.1 Overview
7.4.2 Peritoneal Dialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
8. APAC Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 - Product
8.1 Overview
8.2 APAC Haemodialysis and Peritoneal Dialysis Market Share by Product Segment - 2021 & 2028 (%)
8.3 Devices
8.3.1 Overview
8.3.2 Devices: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.4 Consumables
8.4.1 Overview
8.4.2 Consumables: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.5 Services
8.5.1 Overview
8.5.2 Services: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 - End User
9.1 Overview
9.2 APAC Haemodialysis and Peritoneal Dialysis Market Share by End User Segment - 2021 & 2028 (%)
9.3 Hospital-Based
9.3.1 Overview
9.3.2 Hospital-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9.4 Home-Based
9.4.1 Overview
9.4.2 Home-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 - Country Analysis
10.1 Overview
10.1.1 APAC: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 Japan: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Japan: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.1.3 Japan: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Type (US$ Million)
10.1.1.1.4 Japan: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.1.5 Japan: Haemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 China: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 China: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.2.3 China: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Type (US$ Million)
10.1.1.2.4 China: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.2.5 China: Haemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 India Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.3.3 India: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Type (US$ Million)
10.1.1.3.4 India: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.3.5 India: Haemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 South Korea: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 South Korea: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.4.3 South Korea: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Type (US$ Million)
10.1.1.4.4 South Korea: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.4.5 South Korea: Haemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Australia: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Australia: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
10.1.1.5.3 Australia: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Type (US$ Million)
10.1.1.5.4 Australia: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.5.5 Australia: Haemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of APAC: Haemodialysis and Peritoneal Dialysis Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of APAC: Haemodialysis and Peritoneal Dialysis Market - Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of APAC: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Type (US$ Million)
10.1.1.6.4 Rest of APAC: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028, By Product (US$ Million)
10.1.1.6.5 Rest of APAC: Haemodialysis and Peritoneal Dialysis Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11. Hemodialysis and Peritoneal Dialysis Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Hemodialysis and Peritoneal Dialysis Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Fresenius Medical Care AG & Co KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 DaVita Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Baxter International Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 B. Braun Melsungen AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Diaverum
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Nipro Medical Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Asahi Kasei Medical Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Rockwell Medical, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Dialife SA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

Companies Mentioned

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DaVita Inc.
  • Dialife SA
  • Diaverum
  • Fresenius Medical Care AG & Co KGaA
  • Nipro Medical Corporation
  • Rockwell Medical, Inc

Table Information